PERSPECTIVE THERAPEUTICS, INC. Financing Cash Flow
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Financing Cash Flow of $164.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $147.00K, a 11.36% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $164.36M, a 1548.09% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$13.00K, a 103.77% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $213.00K, a 66.08% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $10.30M, a 96.44% decline from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $289.38M, a 36764.33% increase from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $785.00K, a 2703.57% increase from fiscal 2022.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $28.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $164.51M 10-Q · filed 2026-08-10 | $164.50M derived: sum of 3 quarters · filed 2026-08-10 | $164.71M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $164.36M 10-Q · filed 2026-05-11 | $164.35M derived: sum of 2 quarters · filed 2026-05-11 | $164.56M derived: sum of 3 quarters · filed 2026-05-11 | $164.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $200.00K derived: sum of 2 quarters · filed 2026-03-16 | $332.00K derived: sum of 3 quarters · filed 2026-08-10 | $10.30M 10-K · filed 2026-03-16 |
| 2025-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $345.00K derived: sum of 2 quarters · filed 2026-08-10 | $10.32M 10-Q · filed 2025-11-10 | $10.66M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $10.11M 10-Q · filed 2026-08-10 | $10.45M derived: sum of 3 quarters · filed 2026-08-10 | $11.08M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $9.97M 10-Q · filed 2026-05-11 | $10.32M derived: sum of 2 quarters · filed 2026-05-11 | $10.95M derived: sum of 3 quarters · filed 2026-05-11 | $133.03M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $973.00K derived: sum of 2 quarters · filed 2026-03-16 | $123.06M derived: sum of 3 quarters · filed 2026-03-16 | $289.38M 10-K · filed 2026-03-16 |
| 2024-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $122.71M derived: sum of 2 quarters · filed 2025-11-10 | $289.04M 10-Q · filed 2025-11-10 | $289.39M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $122.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $288.41M 10-Q · filed 2025-08-13 | $288.76M derived: sum of 3 quarters · filed 2025-08-13 | $288.76M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $166.33M 10-Q · filed 2025-05-12 | $166.68M derived: sum of 2 quarters · filed 2025-05-12 | $166.68M derived: sum of 3 quarters · filed 2025-05-12 | $167.19M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $352.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28 | $353.00K derived: sum of 2 quarters · filed 2025-03-28 | $865.00K derived: sum of 3 quarters · filed 2025-03-28 | $785.00K 10-K/A · filed 2025-03-28 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $513.00K derived: sum of 2 quarters · filed 2024-11-12 | $433.00K 10-Q · filed 2024-11-12 | $433.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $432.00K 10-Q · filed 2024-08-13 | $432.00K derived: sum of 3 quarters · filed 2024-08-13 | $460.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$80.00K 10-Q · filed 2024-05-15 | -$80.00K derived: sum of 2 quarters · filed 2024-05-15 | -$52.00K derived: sum of 3 quarters · filed 2024-05-15 | -$52.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | $28.00K 10-K · filed 2024-03-28 | $28.00K derived: sum of 3 quarters · filed 2024-03-28 | $28.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $28.00K 10-Q · filed 2022-11-14 | $28.00K derived: sum of 2 quarters · filed 2023-08-11 | $28.00K 10-Q · filed 2023-11-14 | $84.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $56.00K derived: sum of 3 quarters · filed 2023-08-11 | $56.00K 10-K · filed 2024-03-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $56.00K derived: sum of 2 quarters · filed 2023-05-15 | $56.00K 10-Q · filed 2022-05-13 | $299.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $56.00K derived: 10-KT 6 month − 10-Q 3 month · filed 2023-05-01 | $56.00K 10-KT · filed 2023-05-01 | $299.00K derived: sum of 3 quarters · filed 2023-05-01 | $56.27M derived: sum of 4 quarters · filed 2023-05-01 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $243.00K derived: sum of 2 quarters · filed 2023-05-01 | $56.22M derived: sum of 3 quarters · filed 2023-05-01 | |
| 2021-06-30 | $243.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $56.22M derived: sum of 2 quarters · filed 2023-05-01 | $64.68M 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $55.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $64.44M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $8.46M 10-Q · filed 2022-02-09 | |||
| 2020-06-30 | $874.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | $1.00M derived: sum of 2 quarters · filed 2023-05-01 | $994.00K 10-KT · filed 2023-05-01 | |
| 2020-03-31 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $120.00K 10-Q · filed 2021-05-14 | ||
| 2019-12-31 | -$11.00K 10-Q · filed 2021-02-09 | |||
| 2019-06-30 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $4.00K derived: sum of 2 quarters · filed 2021-09-27 | -$120.00K derived: sum of 3 quarters · filed 2021-09-27 | $7.37M 10-K · filed 2021-09-27 |
| 2019-03-31 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$133.00K derived: sum of 2 quarters · filed 2020-05-13 | $7.36M 10-Q · filed 2020-05-13 | $7.84M derived: sum of 4 quarters · filed 2020-09-25 |
| 2018-12-31 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12 | $7.37M 10-Q · filed 2020-02-12 | $7.85M derived: sum of 3 quarters · filed 2020-09-25 | $7.85M derived: sum of 4 quarters · filed 2020-09-25 |
| 2018-09-30 | $7.49M 10-Q · filed 2019-11-13 | $7.98M derived: sum of 2 quarters · filed 2020-09-25 | $7.98M derived: sum of 3 quarters · filed 2020-09-25 | |
| 2018-06-30 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $482.00K derived: sum of 2 quarters · filed 2020-09-25 | $521.00K 10-K · filed 2020-09-25 | |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $39.00K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $39.00K 10-Q · filed 2019-02-13 | |||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $0.00 derived: sum of 2 quarters · filed 2019-09-27 | -$9.00K 10-K · filed 2019-09-27 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-04 | -$9.00K 10-Q · filed 2018-05-04 | ||
| 2016-12-31 | -$9.00K 10-Q · filed 2018-02-09 | |||
| 2016-06-30 | $39.00K 10-K · filed 2018-09-26 | |||
| 2013-09-30 | $3.28M 10-Q · filed 2013-11-14 | $3.28M derived: sum of 2 quarters · filed 2013-11-14 | $3.28M derived: sum of 3 quarters · filed 2013-11-14 | $3.28M derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $1.82K derived: sum of 2 quarters · filed 2013-09-30 | -$5.21K derived: sum of 3 quarters · filed 2013-09-30 | $3.30M 10-K · filed 2013-09-30 |
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | -$7.04K derived: sum of 2 quarters · filed 2013-05-15 | $3.29M 10-Q · filed 2013-05-15 | $4.09M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-12-31 | -$7.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $3.29M 10-Q · filed 2013-02-14 | $4.09M derived: sum of 3 quarters · filed 2013-11-14 | $4.09M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-09-30 | $3.30M 10-Q · filed 2013-11-14 | $4.10M derived: sum of 2 quarters · filed 2013-11-14 | $4.09M derived: sum of 3 quarters · filed 2013-11-14 | $6.37M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $798.30K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $793.08K derived: sum of 2 quarters · filed 2013-09-30 | $3.06M derived: sum of 3 quarters · filed 2013-09-30 | $3.10M 10-K · filed 2013-09-30 |
| 2012-03-31 | -$5.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $2.27M derived: sum of 2 quarters · filed 2013-05-15 | $2.31M 10-Q · filed 2013-05-15 | $2.92M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $2.31M 10-Q · filed 2013-02-14 | $2.92M derived: sum of 3 quarters · filed 2013-02-14 | $2.91M derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | $40.24K 10-Q · filed 2012-11-14 | $650.88K derived: sum of 2 quarters · filed 2012-11-14 | $637.88K derived: sum of 3 quarters · filed 2012-11-14 | $3.06M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $610.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $597.64K derived: sum of 2 quarters · filed 2012-10-26 | $3.02M derived: sum of 3 quarters · filed 2012-10-26 | $3.01M 10-K/A · filed 2012-10-26 |
| 2011-03-31 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $2.41M derived: sum of 2 quarters · filed 2012-05-15 | $2.40M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $2.42M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | $2.41M 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | -$11.92K 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |